US Patent Issued to Memorial Sloan Kettering Cancer Center, University of Rhode Island Board of Trustees, pHLIP on Feb. 17 for "Radiolabeled ligands for targeted PET/SPECT imaging and methods of their use" (New York, Rhode Island Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,583, issued on Feb. 17, was assigned to Memorial Sloan Kettering Cancer Center (New York), University of Rhode Island Board of Trustees (Kingston, R.I.) and pHLIP Inc. (Kingston, R.I.).

"Radiolabeled ligands for targeted PET/SPECT imaging and methods of their use" was invented by Jason S. Lewis (New York), Dustin Demoin (New York), Yana K. Reshetnyak (Saunderson, R.I.), Oleg A. Andreev (Saunderson, R.I.) and Nerissa Viola-Villegas (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides compounds, complexes, compositions, and methods for the detection of cancer. Specifically, the compounds, complexes, compositions of ...